Merck & Co., Inc. Responds to Journal of the American Medical Association Articles

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. today said it is committed to high standards of scientific integrity and ethics, and believes that many of the comments in a Journal of the American Medical Association (JAMA) news release and in the April 16 issue of JAMA1 related to VIOXX are false, misleading or lack context. The Company said it was not given an opportunity to respond prior to publication. The articles are based on analyses of documents conducted by consultants hired by trial lawyers as part of their work in the VIOXX product liability litigation, and make allegations similar to those previously advanced by these consultants and related attorneys at trial.